Sheldon C. Naiman

1.2k total citations
28 papers, 893 citations indexed

About

Sheldon C. Naiman is a scholar working on Hematology, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sheldon C. Naiman has authored 28 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 7 papers in Surgery and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sheldon C. Naiman's work include Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Sheldon C. Naiman is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Sheldon C. Naiman collaborates with scholars based in Canada, United States and United Kingdom. Sheldon C. Naiman's co-authors include Gershon H. Growe, Thomas Hackmann, Heather J. Sutherland, Gordon E. Pate, S J Klebanoff, Mann Chandavimol, John G. Webb, Thomas R. Austin, Akira Yoshida and G. Stamatoyannopoulos and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Sheldon C. Naiman

27 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheldon C. Naiman Canada	13	391	153	133	101	97	28	893
R. Egbring Germany	22	738 1.9×	202 1.3×	116 0.9×	90 0.9×	145 1.5×	66	1.6k
F.H.J. Claas Netherlands	20	415 1.1×	203 1.3×	411 3.1×	247 2.4×	84 0.9×	45	1.1k
Peter B. Neame Canada	10	288 0.7×	70 0.5×	122 0.9×	48 0.5×	56 0.6×	19	541
David Ciavarella United States	18	502 1.3×	148 1.0×	241 1.8×	455 4.5×	45 0.5×	44	1.3k
Hans‐Gert Heuft Germany	18	255 0.7×	87 0.6×	100 0.8×	91 0.9×	79 0.8×	52	745
S. Gerald Sandler United States	16	389 1.0×	66 0.4×	69 0.5×	165 1.6×	35 0.4×	49	756
William L. Bayer United States	15	312 0.8×	76 0.5×	64 0.5×	105 1.0×	53 0.5×	40	740
G. Andreu France	19	647 1.7×	99 0.6×	308 2.3×	495 4.9×	90 0.9×	68	1.3k
Richard J. Creger United States	19	470 1.2×	74 0.5×	78 0.6×	55 0.5×	115 1.2×	60	986
Jay H. Herman United States	17	412 1.1×	160 1.0×	71 0.5×	319 3.2×	42 0.4×	52	1.0k

Countries citing papers authored by Sheldon C. Naiman

Since Specialization

Citations

This map shows the geographic impact of Sheldon C. Naiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon C. Naiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon C. Naiman more than expected).

Fields of papers citing papers by Sheldon C. Naiman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon C. Naiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon C. Naiman. The network helps show where Sheldon C. Naiman may publish in the future.

Co-authorship network of co-authors of Sheldon C. Naiman

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon C. Naiman. A scholar is included among the top collaborators of Sheldon C. Naiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon C. Naiman. Sheldon C. Naiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Forrest, Donna L., Thomas J. Nevill, Sheldon C. Naiman, et al.. (2003). Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis. Bone Marrow Transplantation. 32(9). 915–923. 37 indexed citations

Kuruvilla, John, Heather A. Leitch, Linda M. Vickars, et al.. (2003). Aplastic anemia following administration of a tumor necrosis factor‐α inhibitor. European Journal Of Haematology. 71(5). 396–398. 43 indexed citations

Leong, Kevin G., et al.. (2002). Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia. American Journal of Hematology. 70(1). 22–30. 34 indexed citations

Gill, Sharlene, et al.. (2002). Massive Bleeding on a Bladder Protectant. Archives of Internal Medicine. 162(14). 1644–1644. 4 indexed citations

Nevill, Thomas J., Henry C. Fung, John D. Shepherd, et al.. (1998). Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation. Blood. 92(6). 1910–1917. 9 indexed citations

Dalal, Bakul I., Vivian C. H. Wu, Douglas E. Horsman, et al.. (1997). Induction Failure inde novoAcute Myelogenous Leukemia is Associated with Expression of High Levels o CD34 Antigen by the Leukemic Blasts. Leukemia & lymphoma. 26(3-4). 299–306. 10 indexed citations

Toze, Cynthia L., Michael J. Barnett, Sheldon C. Naiman, & Douglas E. Horsman. (1997). Trisomy 14 is a non‐random karyotypic abnormality associated with myeloid malignancies. British Journal of Haematology. 98(1). 177–185. 12 indexed citations

Fung, Henry C., John D. Shepherd, Sheldon C. Naiman, et al.. (1995). Acute Monocytic Leukemia: A Single Institution Experience. Leukemia & lymphoma. 19(3-4). 259–265. 7 indexed citations

Growe, Gershon H., Leonard C. Jenkins, & Sheldon C. Naiman. (1991). Anesthesia Training in Transfusion Medicine. Transfusion Medicine Reviews. 5(2). 152–156. 2 indexed citations

10.

Hackmann, Thomas & Sheldon C. Naiman. (1991). Con: Desmopressin is not of value in the treatment of post-cardiopulmonary bypass bleeding. Journal of Cardiothoracic and Vascular Anesthesia. 5(3). 290–293. 9 indexed citations

11.

Hackmann, Thomas, Sheldon C. Naiman, Gershon H. Growe, et al.. (1989). A Trial of Desmopressin (1-Desamino-8-D-Arginine Vasopressin) to Reduce Blood Loss in Uncomplicated Cardiac Surgery. New England Journal of Medicine. 321(21). 1437–1443. 135 indexed citations

12.

Whitney, Stephen, et al.. (1988). CAMAL: A new prognostic marker for remission in acute nonlymphoblastic leukemia. Leukemia Research. 12(1). 19–24.

13.

Reece, Donna, Noel A. Buskard, Roger S. Hill, et al.. (1986). Allogeneic bone marrow transplantation for Philadelphia-chromosome positive acute lymphoblastic leukemia. Leukemia Research. 10(4). 457–459. 9 indexed citations

14.

Vickars, Linda M., Robert Coupland, & Sheldon C. Naiman. (1985). The response of an acquired Factor V inhibitor to activated Factor IX concentrate. Transfusion. 25(1). 51–53. 24 indexed citations

15.

Cooperberg, P L, et al.. (1982). Ultrasonography and computed tomography of hepatic candidiasis in immunosuppressed patients.. Journal of Ultrasound in Medicine. 1(4). 157–159. 15 indexed citations

16.

Durward, Quentin J., et al.. (1979). Intramural hematoma of the gastric cardia.. PubMed. 71(3). 301–5. 10 indexed citations

17.

Cooperberg, P L, et al.. (1977). Ultrasound Diagnosis of Splenic Cysts. Radiology. 122(3). 787–789. 24 indexed citations

18.

Gray, G R, G. Stamatoyannopoulos, Sheldon C. Naiman, et al.. (1973). NEUTROPHIL DYSFUNCTION, CHRONIC GRANULOMATOUS DISEASE, AND NON-SPHEROCYTIC HÆMOLYTIC ANÆMIA CAUSED BY COMPLETE DEFICIENCY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE. The Lancet. 302(7828). 530–534. 125 indexed citations

19.

Naiman, Sheldon C., et al.. (1968). Lymphocyte transformation by phytohemagglutinin: IV. In acute upper respiratory infections.. PubMed Central. 99(10). 467–8. 12 indexed citations

20.

Naiman, Sheldon C., et al.. (1967). Lymphocyte transformation by phytohemagglutinin. II. In the tuberculous patient.. PubMed. 97(14). 836–40. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact